What is Olaratumab used for?
Olaratumab is used along with other medications (such as doxorubicin) to treat a certain type of cancer (soft tissue sarcoma). Olaratumab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.
How should I take Olaratumab?
This medication is given by injection into a vein by a health care professional. It is given as directed by your doctor, usually on days 1 and 8 of each treatment cycle. Each injection is given slowly, usually over at least 60 minutes. The dosage is based on your weight and response to treatment.
Olaratumab may cause serious infusion reactions during or soon after treatment. Your doctor may prescribe other medications (such as diphenhydramine, dexamethasone) before each treatment to help prevent these side effects. Tell your doctor right away if you have any symptoms of infusion reactions such as flushing, trouble breathing, fever, chills, or dizziness.
How do I store Olaratumab?
Different brands of Olaratumab may have different storage needs. It is important to always check the product package for instructions on storage, or ask your pharmacist. For safety, you should keep all medicines away from children and pets.
You should not flush Olaratumab down the toilet or pour them into a drain unless instructed to do so. It is important to properly discard this product when it is expired or no longer needed. Consult your pharmacist for more details about how to safely discard your product.
Precautions & warnings
What should I know before using Olaratumab?
Before receiving olaratumab, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: current/recent infection.
Olaratumab can make you more likely to get infections or may worsen any current infections. Avoid contact with people who have infections that may spread to others (such as chickenpox, measles, flu). Consult your doctor if you have been exposed to an infection or for more details.
Do not have immunizations/vaccinations without the consent of your doctor. Avoid contact with people who have recently received live vaccines (such as flu vaccine inhaled through the nose).
To lower the chance of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports.
Tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant while using olaratumab. Olaratumab may harm an unborn baby. Ask about reliable forms of birth control while using this medication and for 3 months after stopping treatment. If you become pregnant, talk to your doctor right away about the risks and benefits of this medication.
It is unknown if this drug passes into breast milk. Because of the possible risk to the infant, breast-feeding is not recommended while using this drug and for 3 months after treatment. Consult your doctor before breast-feeding.
Is it safe during pregnancy or breast-feeding?
There are no adequate studies in women for determining risk when using this Olaratumab during pregnancy or while breastfeeding. Please always consult with your doctor to weigh the potential benefits and risks before taking Olaratumab. Olaratumab is pregnancy risk category N according to the US Food and Drug Administration (FDA).
FDA pregnancy risk category reference below:
- A=No risk,
- B=No risk in some studies,
- C=There may be some risk,
- D=Positive evidence of risk,
What side effects can occur from Olaratumab?
Nausea, vomiting, diarrhea, abdominal pain, headache, dry eyes, tiredness, muscle/joint pain, numbness/tingling, or loss of appetite may occur. Nausea and vomiting can be severe. In some cases, your doctor may prescribe medication to prevent or relieve nausea and vomiting. Eating several small meals, not eating before treatment, or limiting activity may help lessen some of these effects. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
Pain or sores in the mouth and throat may occur. Brush your teeth carefully/gently, avoid using mouthwash that contains alcohol, and rinse your mouth often with cool water mixed with baking soda or salt. It may also be best to eat soft, moist foods.
Temporary hair loss may occur. Normal hair growth should return after treatment has ended.
People using this medication may have serious side effects. However, your doctor has prescribed this drug because he or she has judged that the benefit to you is greater than the risk ofside effects. Careful monitoring by your doctor may decrease your risk.
Tell your doctor right away if you have any serious side effects, including: easy bruising/bleeding.
This medication may lower your ability to fight infections. This may make you more likely to get a serious (rarely fatal) infection or make any infection you have worse. Tell your doctor right away if you have any signs of infection (such as sore throat that doesn’t go away, fever, chills, cough).
A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
Not everyone experiences these side effects. There may be some side effects not listed above. If you have any concerns about a side-effect, please consult your doctor or pharmacist.
What drugs may interact with Olaratumab?
Olaratumab may interact with other drugs that you are currently taking, which can change how your drug works or increase your risk for serious side effects. To avoid any potential drug interactions, you should keep a list of all the drugs you are using (including prescription drugs, nonprescription drugs and herbal products) and share it with your doctor and pharmacist. For your safety, do not start, stop, or change the dosage of any drugs without your doctor’s approval.
Does food or alcohol interact with Olaratumab?
Olaratumab may interact with food or alcohol by altering the way the drug works or increase the risk for serious side effects. Please discuss with your doctor or pharmacist any potential food or alcohol interactions before using this drug.
What health conditions may interact with Olaratumab?
Olaratumab may interact with your health condition. This interaction may worsen your health condition or alter the way the drug works. It is important to always let your doctor and pharmacist know all the health conditions you currently have.
The information provided is not a substitute for any medical advice. You should ALWAYS consult with your doctor or pharmacist before using this Olaratumab.
What is the dose of Olaratumab for an adult?
Usual Adult Dose for Soft Tissue Sarcoma
15 mg/kg IV over 60 minutes on Days 1 and 8 of each 21-day cycle until disease progression or unacceptable toxicity; for the first 8 cycles of therapy, this drug is administered with doxorubicin
Premedication: Premedicate with diphenhydramine (25 to 50 mg IV) and dexamethasone (10 to 20 mg IV) prior to olaratumab on Day 1 of cycle 1.
-Refer to doxorubicin prescribing information for dosing and dose modifications.
Use: In combination with doxorubicin, for the treatment of adult patients with soft tissue sarcoma (STS) with a histologic subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery
Infusion-Related Reaction (IRR):
-Permanently discontinue therapy for Grade 3 or 4 IRRs.
-Interrupt the infusion for Grade 1 or 2 IRRs; after resolution, resume the infusion at 50% of the initial infusion rate.
-For neutropenic fever/infection or Grade 4 neutropenia lasting longer than 1 week, discontinue therapy until the absolute neutrophil count is 1,000/microliter or greater and then permanently reduce the dose to 12 mg/kg IV.
-Do not administer as an IV push or bolus.
-Do not co-infuse with electrolytes or other medications through the same IV line. -Visually inspect the diluted solution for particulate matter and discoloration prior to administration; if particulate matter or discolorations are present, discard the solution.
-Administer the diluted solution as an IV infusion over 60 minutes; flush the line with sodium chloride 0.09% at the end of the infusion.
What is the dose of Olaratumab for a child?
The dosage has not been established in pediatric patients. It may be unsafe for your child. It is always important to fully understand the safety of the drug before using. Please consult with your doctor or pharmacist for more information.
How is Olaratumab available?
Olaratumab is available in the following dosage forms and strengths:
- Intravenous solution.
What should I do in case of an emergency or overdose?
In case of an emergency or an overdose, call your local emergency services or go to your nearest emergency room.
What should I do if I miss a dose?
If you miss a dose of Olaratumab, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and take your regular dose as scheduled. Do not take a double dose.
Hello Health Group does not provide medical advice, diagnosis or treatment.
Olaratumab Dosage. https://www.drugs.com/dosage/olaratumab.html. Accessed July 6, 2018.
Olaratumab Solution. https://www.webmd.com/drugs/2/drug-172781/olaratumab-intravenous/details. Accessed July 6, 2018.
Review Date: August 10, 2018 | Last Modified: September 12, 2019